OncoLogic

R. Renoux and co-workers, in Th. Klein and co-workers. Biological Response Modifiers in Human Oncology and Immunology, Plenum... [Pg.43]

Promotes research and exchange of information among clinicians and researchers working in the field of environmental toxicology and oncology. [Pg.279]

De Vita VT, Heilman S, Rosenberg SA (2003) Cancer, principles and practice of oncology, 7th edn. Lippincott Williams Wilkins, Philadelphia... [Pg.157]

Astrid Novosel, Arndt Borkhardt Universitat Dusseldorf, Children s University Hospital, Department of Paediatric Haematology Oncology Clinical Immunology, Dusseldorf, Germany... [Pg.185]

Department of Breast Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA... [Pg.218]

At present, the use of microarrays in pharmacology is especially established in the field of oncology by gene expression analysis with either tumour cell... [Pg.528]

At the present time, almost two thirds of all gene-therapy trials target immunological and oncological diseases (Table 2). [Pg.532]

Although in vitro models clearly show that MDR transporters can protect tumor cells, their relevance in clinical oncology remains controver sial. As is the case for most potentially useful cancer biomarkers, no universally embraced guidelines for analytical or clinical validation of MDR transporters exist. Evidence linking ABCB1 Pgp/MDRl expression with poor clinical outcome is most conclusive for breast cancer, sarcoma, and certain types of leukemia. The relevance of the other MDR transporters in clinical MDR is still unclear. The prognostic implication of ABCCl/ MRPl remains controversial and very little is known clinically about ABCG2. [Pg.750]

Department of Medical Oncology, Beaujon University Hospital, Clichy Cedex, France... [Pg.1191]

TA Oncology, Merck Serono Research, Merck KGaA, Darmstadt, Germany... [Pg.1253]

Harari PM (2004) Epidermal growth factor receptor inhibition strategies in oncology. Endocr. Relat. Cancer 11 689-708... [Pg.1257]

Sandrine Faivre Department of Medical Oncology Beaujon University Hospital Clichy Cedex France... [Pg.1515]

Department of Medical Oncology Southampton General Hospital Southampton UK... [Pg.1516]

Most hospitals and clinics require that nurses receive specialized training and standardized educational preparation before they are permitted to administer antineoplastic drug s. The Oncology Nursing Society has developed guidelines and educational tools for creden-tialing nurses for certification in administering chemotherapy. [Pg.595]

Fungizone (Bristol-Myers Squibb, Oncology/ Immunology)... [Pg.109]

USA Blenoxane (Bristol-Myers Squibb Oncology/ Immunology as sulfate)... [Pg.255]

Cinciprinni PM, McClure JB Smoking cessation recent developments in behavioral and pharmacologic interventions. Oncology 12 249-239, 1998 Clarke PB Nicotinic receptor blockade therapy and smoking cessation. Br J Addict 86 501-503, 1991... [Pg.335]

STUART GROSSMAN The Johns Hopkins Oncology Center,... [Pg.43]

Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...